Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
461.50    5.00 (1.10%)
Bid:
455.50
Ask:
460.00
Spread: 4.50 (0.988%)
Market Cap: £160.29m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

Option Grants / PDMR Dealings

11 Feb 2026 10:45

RNS Number : 6197S
Frontier Developments PLC
11 February 2026
 

11 February 2026

Frontier Developments plc

 Option Grants / PDMR Dealings

On 10 February 2026, Frontier Developments plc (AIM: FDEV, 'Frontier', the 'Company', or the 'Group'), a leading developer and publisher of video games based in Cambridge, UKgranted a total of 185,000 options over Ordinary Shares of 0.5p each in the Company ('Ordinary Shares') under the existing Long Term Incentive Plan ('LTIP') to three Executive Directors (the 'Options').

The exercise price of the Options under the LTIP is the nominal value of the Ordinary Shares, being 0.5p each. The Options are due to vest on 10 February 2029, with 50% of the Options vesting subject to the achievement of threshold targets for revenue, profit and shareholder return over the three-year vesting period, and the remaining 50% vesting on a straight-line basis against stretch targets for the three performance measures.

The Options awarded to the Executive Directors are set out in the table below, together with the total number of Ordinary Shares held under option by each of the Executive Directors under all share option schemes.

Name of Director

Position

Number of LTIP options granted on 10 February 2026

Total number of share options held under all schemes following the grants on 10 February 2026

Jo Cooke

Chief Executive Officer

100,000

125,000

David Braben

President and Founder

53,000

233,960

Alex Bevis

Chief Financial Officer

32,000

314,906

Jonny Watts

Executive Director

-

356,635

 

Enquiries:

 

Frontier Developments

IR@frontier.co.uk

+44 (0)1223 394300

Peel Hunt - Nomad and Sole Corporate Broker 

Neil Patel / Ben Cryer / Kate Bannatyne

+44 (0)20 7418 8900

 

About Frontier Developments plc

Frontier Developments plc is a leading independent developer and publisher of video games, specialising in creative management simulation (CMS) experiences. Headquartered in Cambridge, UK, Frontier develops and nurtures globally successful game franchises, including core CMS franchises such as Planet Coaster, Planet Zoo, and Jurassic World Evolution, using its proprietary COBRA technology. The CMS genre underpins Frontier's strategy, which is driving long-term and sustainable growth through strong player engagement, robust back-catalogue performance, and an exciting pipeline of new games.

 

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

www.frontier.co.uk

 

DEALING NOTIFICATION FORMFOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS

  

1.  

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Johanna Cooke

2.  

Reason for the notification

a)

Position/status: Chief Executive Officer

b)

Initial notification/Amendment: Initial Notification

3.  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Grant of 100,000 options over Ordinary Shares of 0.5 pence each with an exercise price of 0.5 pence per share. The Options are due to vest after three years (subject to performance conditions) and must be exercised within 10 years from the date of award.

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.5p

100,000

 

d)

Aggregated information:

N/A - Single transaction

 

e)

Date of the transaction: 10 February 2026

f)

Place of the transaction: Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: David Braben

2.

Reason for the notification

a)

Position/status: President and Founder

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Grant of 53,000 options over Ordinary Shares of 0.5 pence each with an exercise price of 0.5 pence per share. The Options are due to vest after three years (subject to performance conditions) and must be exercised within 10 years from the date of award.

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.5p

53,000

 

d)

Aggregated information:

N/A - Single transaction

 

e)

Date of the transaction: 10 February 2026

f)

Place of the transaction: Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Alexander Bevis

2.

Reason for the notification

a)

Position/status: Chief Financial Officer

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Frontier Developments plc

b)

LEI: 213800B9LGPWUAZ9GX18

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 0.5p each.

Identification code: GB00BBT32N39

b)

Nature of the transaction: Grant of 32,000 options over Ordinary Shares of 0.5 pence each with an exercise price of 0.5 pence per share. The Options are due to vest after three years (subject to performance conditions) and must be exercised within 10 years from the date of award.

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.5p

32,000

 

d)

Aggregated information:

N/A - Single transaction

 

e)

Date of the transaction: 10 February 2026

f)

Place of the transaction: Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAEAFFLDKEFA
Date   Source Headline
1st Jun 202612:05 pmRNSEBT Share Purchase
28th May 20262:30 pmRNS-RPlanet Zoo 2 Announced
22nd May 202611:26 amRNS-RWarhammer 40,000: Chaos Gate – Deathwatch Revealed
22nd May 20269:16 amRNSHolding(s) in Company
19th May 20265:47 pmRNSHolding(s) in Company
18th May 202610:48 amRNSEBT Share Purchase
12th May 20267:00 amRNSTrading Update - FY26 Revenue & Profit Upgraded
23rd Apr 20267:00 amRNSCompletion of Share Buyback Programme
23rd Apr 20267:00 amRNSDirector/PDMR Shareholding
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 202611:05 amRNSHolding(s) in Company
22nd Apr 20267:00 amRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.